内脏脂肪对代谢综合征发作的影响
Hiroto Bushita1,2,3, Naoki Ozato2,3, Kenta Mori2,3
1Department of Medical Data Intelligence, Research Center for Health-Medical Data Science, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Scientific reports
|May 30, 2025
概括
内脏脂肪显著影响代谢综合征 (MetS) 的发生. 使用非侵入性因素,特别是内脏脂肪的新算法,准确地预测了MetS的发展.
科学领域:
- 代谢健康 代谢健康
- 预防医学 预防医学
- 生物统计学 生物统计学
背景情况:
- 代谢综合征 (MetS) 是一个重大的公共卫生挑战.
- 识别MetS的早期预测因素对于及时干预至关重要.
- 内脏脂肪的积累越来越被认为是关键的危险因素.
研究的目的:
- 调查内脏脂肪和代谢综合征发病之间的关联.
- 开发和验证使用非侵入性参数对MetS发病的预测算法.
- 确定对MetS发展的关键贡献因素.
主要方法:
- 来自Iwaki健康促进项目的健康检查数据的分析.
- 使用了213个MetS发病例和1320个非发病例的数据集.
- 开发了一种机器学习算法,结合了七个非侵入性因素,包括内脏脂肪区域.
主要成果:
- 在较高的内脏脂肪面积和MetS发病之间发现了显著的相关性 (p < 0.00001).
- 82厘米2的内脏脂肪区域切断显示出高预测值 (AUC=0.86).
- 开发的算法实现了高准确性 (AUC=0.90训练,0.88测试),其中内脏脂肪作为主要预测因素.
结论:
- 内脏脂肪是预测代谢综合征发病的关键决定因素.
- 已经开发出了一个非常准确的,非侵入性算法,用于MetS发病预测.
- 这种算法为早期检测和预防策略提供了一个有希望的工具.
相关概念视频
Cholesterol: Significance and Regulation
1.3K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.3K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
Hypodermis
7.3K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
7.3K
Coronary Artery Disease I: Introduction
893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248


